Amedica Stock Price, News & Analysis (NASDAQ:AMDA)

$2.18 +0.08 (+3.81 %)
(As of 02/23/2018 04:00 PM ET)
Previous Close$2.18
Today's Range$2.03 - $2.28
52-Week Range$2.03 - $6.96
Volume23,123 shs
Average Volume33,425 shs
Market Capitalization$7.10 million
P/E RatioN/A
Dividend YieldN/A
Beta-1.82

About Amedica (NASDAQ:AMDA)

Amedica logoAmedica Corporation is a commercial biomaterial company. The Company is a vertically integrated silicon nitride orthopedic medical device manufacturer. It is focused on using its silicon nitride ceramic technology platform to develop, manufacture and sell a range of medical devices. It is also engaged in developing wear- and corrosion-resistant implant components for hip and knee arthroplasty. The Company markets its Valeo family of silicon nitride interbody spinal fusion devices in the United States, Europe and Brazil for use in the cervical and thoracolumbar areas of the spine. In addition to its silicon nitride-based spinal fusion products, it markets a line of non-silicon nitride spinal surgery products, which allows the Company to provide surgeons and hospitals with a solution for spinal procedures. Its Valeo interbody spinal fusion devices include Anterior Lumbar, Posterior Lumbar, Oblique Lumbar, Transforaminal Lumbar, Lateral Lumbar, Cervical and Corpectomy.

Receive AMDA News and Ratings via Email

Sign-up to receive the latest news and ratings for AMDA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Devices & Implants
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:AMDA
CUSIPN/A
Phone801-839-3500

Debt

Debt-to-Equity RatioN/A
Current Ratio0.69%
Quick Ratio0.56%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$15.23 million
Price / Sales0.44
Cash FlowN/A
Price / CashN/A
Book Value$3.72 per share
Price / Book0.59

Profitability

Trailing EPSN/A
Net Income$-14,760,000.00
Net Margins-71.07%
Return on Equity-73.86%
Return on Assets-36.96%

Miscellaneous

Employees35
Outstanding Shares3,070,000

Amedica (NASDAQ:AMDA) Frequently Asked Questions

What is Amedica's stock symbol?

Amedica trades on the NASDAQ under the ticker symbol "AMDA."

When did Amedica's stock split? How did Amedica's stock split work?

Shares of Amedica reverse split on Friday, November 10th 2017. The 1-12 reverse split was announced on Friday, November 10th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, November 9th 2017. An investor that had 100 shares of Amedica stock prior to the reverse split would have 8 shares after the split.

How were Amedica's earnings last quarter?

Amedica Co. (NASDAQ:AMDA) issued its quarterly earnings data on Tuesday, November, 21st. The medical equipment provider reported ($0.93) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.94) by $0.01. The medical equipment provider earned $2.96 million during the quarter. Amedica had a negative return on equity of 73.86% and a negative net margin of 71.07%. View Amedica's Earnings History.

When will Amedica make its next earnings announcement?

Amedica is scheduled to release their next quarterly earnings announcement on Tuesday, September, 18th 2018. View Earnings Estimates for Amedica.

Where is Amedica's stock going? Where will Amedica's stock price be in 2018?

2 analysts have issued 1-year price objectives for Amedica's stock. Their predictions range from $60.00 to $60.00. On average, they anticipate Amedica's share price to reach $60.00 in the next year. View Analyst Ratings for Amedica.

Who are some of Amedica's key competitors?

Who are Amedica's key executives?

Amedica's management team includes the folowing people:

  • B. Sonny Bal M.D., Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer (Age 53)
  • Bryan J. McEntire, Chief Technology Officer (Age 63)
  • Dana Lyons, Vice President - Sales and Marketing
  • Eric A. Stookey, Independent Director (Age 44)
  • David W. Truetzel CPA, Independent Director (Age 58)
  • Jeffrey S. White, Independent Director (Age 61)

Who owns Amedica stock?

Amedica's stock is owned by many different of retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (2.59%). View Institutional Ownership Trends for Amedica.

Who sold Amedica stock? Who is selling Amedica stock?

Amedica's stock was sold by a variety of institutional investors in the last quarter, including Renaissance Technologies LLC. View Insider Buying and Selling for Amedica.

How do I buy Amedica stock?

Shares of Amedica can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Amedica's stock price today?

One share of Amedica stock can currently be purchased for approximately $2.18.

How big of a company is Amedica?

Amedica has a market capitalization of $7.10 million and generates $15.23 million in revenue each year. Amedica employs 35 workers across the globe.

How can I contact Amedica?

Amedica's mailing address is 1885 WEST 2100 SOUTH, SALT LAKE CITY UT, 84119. The medical equipment provider can be reached via phone at 801-839-3500 or via email at [email protected]


MarketBeat Community Rating for Amedica (AMDA)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  119 (Vote Outperform)
Underperform Votes:  66 (Vote Underperform)
Total Votes:  185
MarketBeat's community ratings are surveys of what our community members think about Amedica and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Amedica (NASDAQ:AMDA) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldBuy
Consensus Rating Score: 2.002.002.003.00
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $60.00$60.00$60.00$60.00
Price Target Upside: 1,654.39% upside1,654.39% upside18,361.54% upside1,215.79% upside

Amedica (NASDAQ:AMDA) Consensus Price Target History

Price Target History for Amedica (NASDAQ:AMDA)

Amedica (NASDAQ:AMDA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/24/2018Maxim GroupReiterated RatingHoldLowView Rating Details
11/27/2017Ladenburg Thalmann Financial ServicesDowngradeBuy -> NeutralHighView Rating Details
(Data available from 2/23/2016 forward)

Earnings

Amedica (NASDAQ:AMDA) Earnings History and Estimates Chart

Earnings by Quarter for Amedica (NASDAQ:AMDA)

Amedica (NASDAQ AMDA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
9/18/2018        
11/21/2017Q3 2017($0.94)($0.93)$2.96 millionViewN/AView Earnings Details
9/19/2017Q4 2016($3.12)$3.65 millionViewN/AView Earnings Details
11/10/2016Q316($2.40)($3.60)$4.11 million$3.40 millionViewN/AView Earnings Details
8/11/2016Q216($3.72)($4.80)$4.20 million$4.00 millionViewListenView Earnings Details
5/12/2016Q116($3.00)($3.60)$4.98 million$4.20 millionViewListenView Earnings Details
11/12/2015Q315($0.72)($1.80)$5.00 million$4.80 millionViewN/AView Earnings Details
8/13/2015Q2 2015($19.80)$4.78 millionViewN/AView Earnings Details
5/7/2015Q1 2015($36.00)$4.74 millionViewN/AView Earnings Details
3/5/2015Q4 2014($46.80)$5.15 millionViewN/AView Earnings Details
11/6/2014Q314($6.12)($4.68)$5.95 million$6.00 millionViewN/AView Earnings Details
8/7/2014Q2 2014($192.58)$5.84 millionViewN/AView Earnings Details
5/15/2014Q1 2014($142.19)$5.78 millionViewN/AView Earnings Details
3/31/2014Q413($40.20)$10.44$5.45 million$5.70 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Amedica (NASDAQ:AMDA) Earnings Estimates

Current Year EPS Consensus Estimate: $-6.12 EPS
Next Year EPS Consensus Estimate: $-2.93 EPS

Dividends

Dividend History for Amedica (NASDAQ:AMDA)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Amedica (NASDAQ AMDA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.10%
Institutional Ownership Percentage: 29.03%
Insider Trades by Quarter for Amedica (NASDAQ:AMDA)

Amedica (NASDAQ AMDA) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/10/2015Ty LombardiVPBuy25,000$0.40$10,000.0051,971View SEC Filing  
12/11/2014David W TruetzelDirectorSell15,000$0.68$10,200.00View SEC Filing  
12/8/2014Jeffrey S WhiteDirectorBuy9,600$0.62$5,952.00View SEC Filing  
2/18/2014David W TruetzelDirectorBuy5,000$5.82$29,100.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Amedica (NASDAQ AMDA) News Headlines

Source:
DateHeadline
Second Sight Medical Products (EYES) and Amedica (AMDA) Critical SurveySecond Sight Medical Products (EYES) and Amedica (AMDA) Critical Survey
www.americanbankingnews.com - February 9 at 1:14 AM
Smith & Nephew (SNN) & Amedica (AMDA) Head to Head ContrastSmith & Nephew (SNN) & Amedica (AMDA) Head to Head Contrast
www.americanbankingnews.com - January 28 at 3:18 PM
AMEDICA PROVIDES BUSINESS UPDATEAMEDICA PROVIDES BUSINESS UPDATE
finance.yahoo.com - January 25 at 3:40 PM
Maxim Group Reaffirms Hold Rating for Amedica (AMDA)Maxim Group Reaffirms Hold Rating for Amedica (AMDA)
www.americanbankingnews.com - January 24 at 11:18 PM
Financial Analysis: Glaukos (GKOS) versus Amedica (AMDA)Financial Analysis: Glaukos (GKOS) versus Amedica (AMDA)
www.americanbankingnews.com - January 17 at 1:28 AM
Amedica (AMDA) versus The Competition Critical SurveyAmedica (AMDA) versus The Competition Critical Survey
www.americanbankingnews.com - January 6 at 7:14 PM
Comparing Amedica (AMDA) and Its RivalsComparing Amedica (AMDA) and Its Rivals
www.americanbankingnews.com - January 5 at 11:08 PM
Critical Contrast: Amedica (AMDA) & Its PeersCritical Contrast: Amedica (AMDA) & Its Peers
www.americanbankingnews.com - January 3 at 9:44 PM
Critical Contrast: Amedica (AMDA) vs. Its RivalsCritical Contrast: Amedica (AMDA) vs. Its Rivals
www.americanbankingnews.com - December 28 at 3:44 PM
Amedica (AMDA) & Its Competitors Critical SurveyAmedica (AMDA) & Its Competitors Critical Survey
www.americanbankingnews.com - December 24 at 5:34 PM
Zacks: Analysts Set $4.35 Target Price for Amedica Co. (AMDA)Zacks: Analysts Set $4.35 Target Price for Amedica Co. (AMDA)
www.americanbankingnews.com - December 18 at 3:52 PM
Contrasting Amedica (AMDA) & Its PeersContrasting Amedica (AMDA) & Its Peers
www.americanbankingnews.com - December 18 at 3:10 PM
Stryker (SYK) versus Amedica (AMDA) Financial ComparisonStryker (SYK) versus Amedica (AMDA) Financial Comparison
www.americanbankingnews.com - December 18 at 11:50 AM
Head to Head Comparison: Amedica (AMDA) & Its PeersHead to Head Comparison: Amedica (AMDA) & Its Peers
www.americanbankingnews.com - December 16 at 3:26 AM
ETFs with exposure to Amedica Corp. : December 15, 2017ETFs with exposure to Amedica Corp. : December 15, 2017
finance.yahoo.com - December 15 at 3:44 PM
Amedica (AMDA) vs. Stryker (SYK) Head to Head SurveyAmedica (AMDA) vs. Stryker (SYK) Head to Head Survey
www.americanbankingnews.com - December 13 at 11:16 AM
Head to Head Comparison: Amedica (AMDA) vs. Its PeersHead to Head Comparison: Amedica (AMDA) vs. Its Peers
www.americanbankingnews.com - December 12 at 5:16 PM
Amedica (AMDA) vs. The Competition Head to Head AnalysisAmedica (AMDA) vs. The Competition Head to Head Analysis
www.americanbankingnews.com - December 9 at 9:36 AM
Contrasting Amedica (AMDA) and Its RivalsContrasting Amedica (AMDA) and Its Rivals
www.americanbankingnews.com - December 9 at 9:36 AM
ETFs with exposure to Amedica Corp. : December 5, 2017ETFs with exposure to Amedica Corp. : December 5, 2017
finance.yahoo.com - December 5 at 1:01 PM
Amedica (AMDA) Rating Lowered to Sell at ValuEngineAmedica (AMDA) Rating Lowered to Sell at ValuEngine
www.americanbankingnews.com - December 3 at 11:40 PM
Amedica Receives Positive Nasdaq Listing Decision Nasdaq:AMDA - GlobeNewswire (press release)Amedica Receives Positive Nasdaq Listing Decision Nasdaq:AMDA - GlobeNewswire (press release)
globenewswire.com - December 2 at 8:00 AM
Amedica Corp. :AMDA-US: Earnings Analysis: Q3, 2017 By the Numbers : December 1, 2017Amedica Corp. :AMDA-US: Earnings Analysis: Q3, 2017 By the Numbers : December 1, 2017
finance.yahoo.com - December 1 at 6:32 PM
Blog Exposure - Hologic Gets FDA Clearance for Quantra(TM) 2.2 Breast Density Assessment SoftwareBlog Exposure - Hologic Gets FDA Clearance for Quantra(TM) 2.2 Breast Density Assessment Software
finance.yahoo.com - November 28 at 9:09 AM
Ladenburg Thalmann Financial Services Lowers Amedica Corporation (AMDA) to HoldLadenburg Thalmann Financial Services Lowers Amedica Corporation (AMDA) to Hold
www.americanbankingnews.com - November 27 at 10:10 AM
Amedicas (AMDA) CEO Sonny Bal on Q3 2017 Results - Earnings Call TranscriptAmedica's (AMDA) CEO Sonny Bal on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 21 at 4:19 PM
Amedicas (AMDA) CEO Sonny Bal on Q3 2017 Results - Earnings Call TranscriptAmedica's (AMDA) CEO Sonny Bal on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 21 at 4:19 PM
Amedica Corp. to Host Earnings CallAmedica Corp. to Host Earnings Call
finance.yahoo.com - November 21 at 4:19 PM
Breaking Down Amedica Corporation’s (AMDA) Ownership StructureBreaking Down Amedica Corporation’s (AMDA) Ownership Structure
finance.yahoo.com - November 21 at 4:19 PM
Amedica Corporation (AMDA) Announces  Earnings Results, Misses Estimates By $10.21 EPSAmedica Corporation (AMDA) Announces Earnings Results, Misses Estimates By $10.21 EPS
www.americanbankingnews.com - November 21 at 7:34 AM
Amedica Corporation to Review Third Quarter 2017 Financial Results and Host Conference Call - GlobeNewswire (press release)Amedica Corporation to Review Third Quarter 2017 Financial Results and Host Conference Call - GlobeNewswire (press release)
globenewswire.com - November 17 at 8:31 PM
Does Amedica Corporation’s (AMDA) Debt Level Pose A Serious Problem?Does Amedica Corporation’s (AMDA) Debt Level Pose A Serious Problem?
finance.yahoo.com - November 16 at 11:05 AM
Amedica Corporation to Review Third Quarter 2017 Financial Results and Host Conference CallAmedica Corporation to Review Third Quarter 2017 Financial Results and Host Conference Call
finance.yahoo.com - November 16 at 11:05 AM
Amedica (AMDA) Announces 1-for-12 Reverse Stock Split; to Trade on Split-Adjusted Basis on Friday, November 10Amedica (AMDA) Announces 1-for-12 Reverse Stock Split; to Trade on Split-Adjusted Basis on Friday, November 10
www.streetinsider.com - November 12 at 3:49 PM
Amedica Corporation (AMDA) Stock Rating Upgraded by ValuEngineAmedica Corporation (AMDA) Stock Rating Upgraded by ValuEngine
www.americanbankingnews.com - November 11 at 7:38 PM
Amedica Announces Reverse Stock Split - NasdaqAmedica Announces Reverse Stock Split - Nasdaq
www.nasdaq.com - November 10 at 2:22 PM
Amedica Announces Reverse Stock SplitAmedica Announces Reverse Stock Split
finance.yahoo.com - November 10 at 2:22 PM
Amedica (AMDA) Reports Submission of 510(k) Application to FDA ... - StreetInsider.comAmedica (AMDA) Reports Submission of 510(k) Application to FDA ... - StreetInsider.com
www.streetinsider.com - November 7 at 3:01 AM
Amedica Submits 510(k) Application to FDA for Valeo C+CSC with LumenAmedica Submits 510(k) Application to FDA for Valeo C+CSC with Lumen
finance.yahoo.com - November 6 at 4:36 PM
Amedica Announces Podium Presentations and Participation at NASS 2017Amedica Announces Podium Presentations and Participation at NASS 2017
finance.yahoo.com - October 23 at 4:54 PM
Amedica (AMDA) Announces Positive Nasdaq Listing Decision - StreetInsider.comAmedica (AMDA) Announces Positive Nasdaq Listing Decision - StreetInsider.com
www.streetinsider.com - October 17 at 4:38 PM
Amedica Receives Positive Nasdaq Listing DecisionAmedica Receives Positive Nasdaq Listing Decision
finance.yahoo.com - October 17 at 4:38 PM
UPDATE: Maxim Group Downgrades Amedica Corporation (AMDA) to HoldUPDATE: Maxim Group Downgrades Amedica Corporation (AMDA) to Hold
www.streetinsider.com - September 27 at 8:07 PM
Amedica Corporation (AMDA) Downgraded by Maxim Group to HoldAmedica Corporation (AMDA) Downgraded by Maxim Group to Hold
www.americanbankingnews.com - September 25 at 2:14 PM
Amedica Releases First and Second Quarter 2017 Preliminary Unaudited Earnings Report and Business UpdateAmedica Releases First and Second Quarter 2017 Preliminary Unaudited Earnings Report and Business Update
feeds.benzinga.com - September 22 at 9:49 AM
Amedica Receives Nasdaq Listing Determination; Plans to Request Hearing - BenzingaAmedica Receives Nasdaq Listing Determination; Plans to Request Hearing - Benzinga
www.benzinga.com - August 26 at 3:36 PM
Amedica Receives Nasdaq Listing Determination; Plans to Request HearingAmedica Receives Nasdaq Listing Determination; Plans to Request Hearing
finance.yahoo.com - August 25 at 5:23 PM
Amedica Receives Nasdaq Listing Determination; Plans to Request HearingAmedica Receives Nasdaq Listing Determination; Plans to Request Hearing
finance.yahoo.com - August 25 at 5:23 PM
Amedica Announces Adjournment of Special Meeting of StockholdersAmedica Announces Adjournment of Special Meeting of Stockholders
finance.yahoo.com - August 14 at 9:08 PM
Medical Equipment Stock Performance Review -- Amedica, Neovasc, Accuray, and NuVasive - PR Newswire (press release)Medical Equipment Stock Performance Review -- Amedica, Neovasc, Accuray, and NuVasive - PR Newswire (press release)
www.prnewswire.com - July 21 at 5:25 PM

SEC Filings

Amedica (NASDAQ:AMDA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Amedica (NASDAQ:AMDA) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Amedica (NASDAQ AMDA) Stock Chart for Friday, February, 23, 2018

Loading chart…

This page was last updated on 2/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.